Journal Article Summary
The article investigates the effectiveness and safety of a dual therapy regimen combining vonoprazan and amoxicillin for treating Helicobacter pylori (H. pylori) infections in elderly patients, specifically those aged 60 and older. This topic is significant because H. pylori infections can lead to serious gastrointestinal issues, and the elderly population often faces unique health challenges, including multiple chronic conditions and increased vulnerability to medication side effects. Understanding how this treatment works in older adults is crucial for ensuring safe and effective care.
In this retrospective study, data were collected from 380 elderly patients who received vonoprazan-amoxicillin dual therapy either as a first-line or rescue treatment for H. pylori. The treatment involved taking vonoprazan twice daily and amoxicillin three times daily for 14 days. The results showed a high eradication rate of 95.6% in the first-line treatment group and 89.2% in the rescue treatment group, with a low incidence of adverse events (AEs) at 9.5%. Most patients adhered well to the treatment, with only five discontinuing due to side effects, none of which were severe.
However, the study has limitations, including its retrospective nature, which may introduce biases and limit the generalizability of the findings. The reliance on existing medical records could also lead to incomplete data. Patients and caregivers should discuss these results with healthcare professionals to weigh the benefits and risks of this treatment, especially considering the unique health profiles of elderly patients. Further research, including larger and more controlled studies, is needed to confirm these findings and ensure the safety and efficacy of this therapy in diverse populations.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Gao Wen, Li Jing-Wen, Ye Hui, Zhang Xue-Zhi, Liu Jian-Xiang, Cheng Hong. Real-world evidence on the efficacy and safety of vonoprazan-amoxicillin dual therapy for Helicobacter pylori treatment in elderly patients. World Journal of Gastroenterology 2025. DOI: 10.3748/wjg.v31.i1.101463. PMID: 39777248. PMCID: PMC11684175.
Featured Pill Pals Product
Amoxicillin 875 mg / Clavulanate 125 mg Combination Tablets --- Generic For Augmentin --- Aurobindo
Amoxicillin 875 mg / Clavulanate 125 mg Combination Tablets — Generic For Augmentin — Aurobindo is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
